Fact CheckerSign in

NCT05443607Active, not recruiting

Transplacental Transmission of RSV (TTRSV)

A Prospective Cohort Study Evaluating the Transplacental Transmission of Respiratory Syncytial Virus (RSV) in Pregnant Women and Their Offspring

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

Aim 1: To study transplacental transmission of Respiratory Syncytial Virus (RSV) and how this is moderated by other maternal infections during pregnancy Aim 2: To test maternal blood for presence of RSV-specific immunoglobulins and how this is moderated by other maternal infections during pregnancy Aim 3: To test cord blood (fetal blood) for presence of RSV-specific immunoglobulins and other common viral pathogens Aim 4: To perform further tests (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Droplet Digital Polymerase Chain Reaction (ddPCR) and immunoprobing) to confirm the presence of RSV and other common viral pathogens Aim 5: To follow these newborn infants up to 4 years of age to look for redisposition to respiratory diseases and growth parameters

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
300 (actual)
First submitted
29 Jun 2022
Start date
May 2020
Primary completion date
Aug 2027
Lead sponsor
Tulane University
Diseases
Asthma
NCT number
NCT05443607

What you commit to

  • Study type: Observational
  • Participants enrolled: 300
  • From May 2020 to the primary completion date, Aug 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of immunosuppressive therapies/drugs.

Other illness

  • Does not report at least 2 of the following signs and symptoms of respiratory infection during pregnancy, including but not limited to: fever, nasal congestion/discharge, cough, and sore throat.
  • Positive medical history for HIV.
  • Newborn has been diagnosed with congenital abnormality or chronic disease at birth.

Age

  • Under 18 years of age at the time of consent.
  • Gestational age less than 12.0 weeks at the time of consent.
  • Subject is unwilling to allow for follow up of the child via medical records from the time of delivery to 4 years of age;

Other

  • Unwilling or unable to provide written informed consent.
  • Mother was not pregnant during the RSV season or no positive SARS-CoV-2 test during pregnancy.
  • Multiple birth;
  • Lacks English or Spanish proficiency
    • Infants will be excluded from the study in the event of a Serious Adverse Event such as fetal or acute neonatal death (in the delivery room) if the mother does not provide clinical consent for an autopsy.

Who the study is looking for

  • Aged 18 years or older;
  • Reported 2 or more signs and symptoms of respiratory infection during pregnancy, including but not limited to: fever, nasal congestion/discharge, cough, and sore throat and/or a positive SARS-CoV-2 test
  • Deliveries at full term or near term (minimum 34 weeks gestation) in Labor and Delivery (L\&D) facilities at Tulane Lakeside Hospital and Clinic or Ochsner Baptist Medical Center who were pregnant during RSV season.
  • History negative for Human Immunodeficiency Virus (HIV)
  • No use of immunosuppressive medications/therapies.
  • Singleton gestation;
  • Willing to allow for follow up of the child via their medical record from the time of delivery to 4 years of age.
  • Clearly understands the study procedures and visit schedule, alternative treatments, and risks involved with the study, and voluntarily agrees to participate by giving written informed consent.
  • English or Spanish proficiency

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tulane University Lakeside Hospital
Coordinator of this site? Confirm its status
MetairieUnited StatesUnknown status
Ochsner Baptist Hospital
Coordinator of this site? Confirm its status
New OrleansUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.